According to Jinshi Data, due to favorable factors such as the growth of the innovative drug market and the expectation of the Federal Reserve's interest rate cut, funds have continued to flow into the Hong Kong stock innovative drug ETF recently. As of December 17, the fund has received net purchases for 6 consecutive trading days, with the latest share reaching 10.1 billion shares, a record high. This is the first Hong Kong stock innovative drug theme ETF fund in the market with a share exceeding 10 billion shares.
See original
Hong Kong Stock Innovative Drug ETF Shares Exceed 10 Billion, Setting a New Record
AI Summary
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
Replies 0